Skip to main content
Equibles

DEERFIELD MANAGEMENT COMPANY, L.P.

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1009258 NEW YORK, NY
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$60,105,534
-$150,076 QoQ
Shares Held
7,503,812
0.0% QoQ
Ownership
7.55%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#4
of 209 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEERFIELD MANAGEMENT COMPANY, L.P. holds $3,763,549,987 across 45 Biotechnology names. SPRY ranks #21 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,392,000 $447,973,760
2 PRAX
Praxis Precision Medicines, Inc.
 963,351 $322,520,281
3 LEGN
Legend Biotech Corp
 8,137,638 $235,014,985
4 COGT
Cogent Biosciences, Inc.
 5,006,104 $193,736,224
5 GMAB
Genmab A/S
 6,865,000 $188,581,550
6 VERA
Vera Therapeutics, Inc.
 3,916,400 $168,052,724
7 IONS
Ionis Pharmaceuticals Inc
 1,979,669 $156,967,955
8 CELC
Celcuity Inc.
 1,451,014 $151,805,084

All Filings in SPRY

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $60,105,534 7,503,812
2026-03-31 $60,255,610 7,503,812
2025-12-31 $87,419,409 7,503,812
2025-09-30 $75,413,310 7,503,812
2025-06-30 $169,692,664 9,724,508
2025-03-31 $132,274,385 10,514,657
2024-12-31 $110,929,631 10,514,657
2024-09-30 $160,629,941 11,077,927
2024-06-30 $94,273,158 11,077,927
2024-03-31 $113,216,413 11,077,927
2023-12-31 $60,707,039 11,077,927
2023-09-30 $41,874,564 11,077,927
2023-06-30 $74,222,110 11,077,927
2023-03-31 $72,117,304 11,077,927
2022-12-31 $94,494,717 11,077,927